DexCare, a Seattle, WA-based patient demand and care access platform, closed $75 million in Series C funding, bringing its total raised to $146 million.
The round was led by ICONIQ Growth, with participation from existing partners Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.
The fresh funds will be utilized to further develop DexCare's platform, which aims to extend limited health-system capacity by efficiently managing the supply and demand of digital-care access.
Funding will advance DexCare’s product portfolio of innovation to help U.S. healthcare systems capture consumers, manage limited resources, and control costs to fuel growth.
DexCare is a care-access platform to manage the logistics of digital-care delivery. It enables healthcare systems to forecast and predict demand while also managing the merchandising of care services to consumers across the digital ecosystem.
“We’re staring at a new era of care delivery,” Derek Streat, CEO of DexCare, said, “and this financing validates DexCare’s impact to modernize health commerce, from how care is accessed and orchestrated to delivered. With the backing of our investors, partners, and customers, we’re overhauling an antiquated industry to ensure patients are matched to the right provider, at the right time, and in the right setting.”
Company: DexCare, Inc.
Round: Series C
Funding Month: June 2023
Lead Investors: ICONIQ Growth
Additional Investors: Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures
Company Website: https://dexcare.com/
Software Category: Patient Demand and Care Access Platform
About the Company: DexCare is a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care. DexCare is on a mission to expand access to care for everyone. Its platform extends limited health-system capacity to ensure patients are matched to the right provider at the right time and in the right setting. Today, The company serves more than 57 million patients across 50 states and partners with leading U.S. health systems, including Kaiser Permanente, Providence, and Community Health Network.